H.C. Wainwright Downgrades Aratana Therapeutics (PETX) to Neutral Following Acquisition
Tweet
Share
E-mailGet Alerts PETX Hot Sheet
Price: $4.92 --0%
Rating Summary:
7 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
7 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
H.C. Wainwright downgraded Aratana Therapeutics (NASDAQ: PETX) from Buy to Neutral.
For an analyst ratings summary and ratings history on Aratana Therapeutics click here. For more ratings news on Aratana Therapeutics click here.
Shares of Aratana Therapeutics closed at $3.43 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- RBC Capital Downgrades Accelerant Holdings (ARX) to Sector Perform
- Goldman Sachs Downgrades Douglas AG (DOU:GR) to Sell
- Desjardins Downgrades Alithya Group Inc. (ALYA:CN) (ALYA) to Hold
Create E-mail Alert Related Categories
DowngradesRelated Entities
H.C. WainwrightSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
